the significance of variant allele frequency in patients with sf3b1-mutated mds
Published 7 months ago • 370 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
3:46
variant allele frequency in patients with sf3b1-mutated mds
-
2:34
sf3b1-mutant mds: a new disease subtype
-
3:10
the role of ngs in mds diagnosis
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
5:38
the molecular and clinical classifications of mds
-
15:20
t0-1458 -cancer cytogenetics leukemia
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
1:02:01
june 2023 labcop extended echo session: the world health assembly diagnostic capacity resolution
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
2:44
bmt ctn 1506/morpho: flt3-itd variant allele frequency and mrd data
-
1:17
the curative potential of allosct in the treatment of hr-mds
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
1:04
the future of mds management
-
0:47
overview of the phase iii enhance trial schema
-
1:37
the importance of mrd assessment before allosct in all
-
4:35
lower-risk mds in 2021: luspatercept, imetelstat & roxadustat
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial